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Formaldehyde (FA) is an industrial chemical
used for manufacturing building materials
and household products. It is also found in
automobile emissions and tobacco smoke.
Inhalation of FA induces sensory irritation at
relatively low concentrations in experimental
animals as well as in humans (Alexandersson
and Hedenstierna 1988; Kane and Alarie
1977). Although animal studies investigating
the genotoxic potential of FA did not generate
deﬁnitive results (Dallas et al. 1992; Migliore
et al. 1989), FA is carcinogenic at the site of
contact as a consequence of epithelial cell
regenerative proliferation resulting from cyto-
toxicity and mutation (reviewed by Naya and
Nakanishi 2005). In 2004 the International
Agency for Research on Cancer (IARC) con-
cluded that FA is a known human carcinogen
based on sufﬁcient evidence in humans and
experimental animals (IARC 2004).
Sick building syndrome (SBS) is the suite
of adverse health effects caused by serious
indoor air quality problems in homes, ofﬁces,
and other work places. The syndrome is gen-
erally characterized by mucosal irritation and
nonspecific hypersensitivity. Although the
specific cause of the syndrome has not been
identiﬁed, the accumulation of chemical and
biological contaminants from indoor sources
because of inadequate ventilation is regarded
as the main factor inducing SBS. Along with
many other factors, exposure to FA indoors
could contribute to the syndrome. It has been
suggested that the recent increase in allergic
diseases such as asthma and allergic rhinitis is
related to exposure to environmental pollu-
tants such as FA (Takafuji and Nakagawa
2000).
FA is metabolized into formic acid by
aldehyde dehydrogenase, which is further
oxidized to carbon dioxide or may serve as a
one-carbon donor in tetrahydrofolate-depen-
dent synthesis of purine, pyrimidine, and
amino acids. Because of its rapid metabolism
and exhalation, however, exposure to FA
does not always result in an increased blood
or urine concentration of parent compound
in animals or humans (Gottschling et al.
1984; Heck et al. 1985). Therefore, the
development of biomarkers for FA exposure
and toxicity is necessary for risk assessment.
Thiazolidine-4-carboxylate (TZCA) is
formed by a nonenzymatic condensation
reaction of L-cysteine with a variety of amine-
derived aldehydes or carbonyl compounds,
including FA (Ratner and Clarke 1937). We
recently found that the urinary concentration
of TZCA reﬂects the degree of FA exposure
very well (Shin et al., in press). Therefore, we
measured the urinary concentration of
TZCA as a marker for FA exposure.
The identification of differentially
expressed genes or patterns of gene expression
using a microarray hybridization assay pro-
vides a logical approach to developing poten-
tial biomarkers of toxicity. Hundreds of
publications have suggested the use of bio-
markers for the diagnosis and prognosis of
disease, as well as for the assessment of expo-
sure to xenobiotics in cells and animal tissues.
However, only a very limited number of can-
didate gene markers can ultimately be used in
human samples. The reasons for this include
the inaccuracy of microarray data, discrepan-
cies among in vitro, in vivo, and human stud-
ies, and the lack of validation of the in vitro
or in vivo data in human samples. To this
end, we investigated the effects of FA on gene
expression in human tracheal ﬁbroblast and
validated the results in human samples with
varying degrees of FA exposure. Our overall
goal was to identify global changes in gene
expression following FA exposure to produce
mechanistic insight into FA-induced toxicity
and to provide potential biomarkers that can
be used in risk assessment for FA exposure.
Materials and Methods
Cells and chemicals. The Hs 680.Tr human
tracheal ﬁbroblast cell line was maintained in
RPMI-1640 medium supplemented with
10% fetal bovine serum (FBS) in a 5% CO2
atmosphere at 37°C. The culture medium
does not contain cysteine. FA, TZCA, and
2-methyl-TZCA were purchased from
Sigma Chemical Co. (St. Louis, MO, USA).
Cell viability measurement. We incu-
bated the cells with various concentrations
(0, 20, 50, 100, and 200 µM) of FA for 4
and 24 hr. Aqueous solution of FA (37%)
was added directly to the incubation media.
Cell viability was measured using the 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetra-
zolium bromide (MTT) cell proliferation
assay.
RNA isolation. Total RNA was extracted
using an Easy-Blue total RNA extraction kit
(Intron Biotech, Sungnam, Korea), puriﬁed
using Qiagen RNeasy Mini Kits (Qiagen,
Basel, Switzerland), and examined for
integrity using an Agilent 2100 Bioanalyzer
(Ambion, Austin, TX, USA).
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BACKGROUND: Formaldehyde (FA) is classified as a human carcinogen and has been linked to
increased leukemia rates in some epidemiologic studies. Inhalation of FA induces sensory irritation
at relatively low concentrations. However, little is known concerning the cellular alterations
observed after FA exposure in humans.
OBJECTIVES: Our aim was to proﬁle global gene expression in Hs 680.Tr human tracheal ﬁbroblasts
exposed to FA and to develop biomarkers for the evaluation of FA exposure in humans.
METHODS AND RESULTS: We used gene expression analysis, and identiﬁed 54 genes designated as
FA responsive. On the basis of these data, we conducted an exploratory analysis of the expression of
these genes in human subjects exposed to high or low levels of FA. We monitored FA exposure by
measuring the urinary concentration of thiazolidine-4-carboxylate (TZCA), a stable and quantita-
tive cysteinyl adduct of FA. Nine genes were selected for real-time PCR analysis; of these,
BHLHB2, CCNL1, SE20-4, C8FW, PLK2, and SGK showed elevated expression in subjects with
high concentrations of TZCA.
CONCLUSION: The identiﬁcation of gene marker candidates in vitro using microarray analysis and
their validation using human samples obtained from exposed subjects is a good tool for discovering
genes of potential mechanistic interest and biomarkers of exposure. Thus, these genes are differen-
tially expressed in response to FA and are potential effect biomarkers of FA exposure.
KEY WORDS: biomarker, carcinogenesis, formaldehyde, human study, microarray, toxicogenomics.
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analysis. To analyze differential gene expres-
sion profiles, we used Sentrix HumanRef-8
Expression BeadChips (Illumina, San Diego,
CA, USA) containing more than 23,000
genes. A detailed description of the BeadChip
system has been provided elsewhere (Kuhn
et al. 2004). Brieﬂy, biotinylated cRNA was
prepared and linearly ampliﬁed from 1.5 µg
of total RNA using an Illumina RNA
Amplification kit (Ambion) and purified
using the Qiagen RNeasy kit (Qiagen).
Hybridization, washing, and scanning were
performed according to the Illumina
BeadStation 500 manual (Kuhn et al. 2004).
The quality of hybridization and overall chip
performance were monitored by visual
inspection of both internal quality control
checks and the raw scanned data. Data were
filtered by the detection score, which is
1 minus the p-value computed from the
background model, characterizing the
chance that the target sequence signal was
distinguishable from the negative controls. A
total of 15,262 probes had a detection score
that was greater than the average score in
more than four of eight measurements, and
these probes were analyzed further. Data were
extracted using the software provided by the
manufacturer (BeadStudio, version 1.0.0.5)
and subjected to quantile normalization.
One-way analysis of variance (ANOVA) and
Tukey’s HSD test were applied to distin-
guish differentially expressed sets of genes
across the three experimental groups.
Statistical signiﬁcances were adjusted by the
Benjamini-Hochberg FDR multiple-testing
correction. Hierarchical clustering was per-
formed using the Euclidean method.
Biological pathway and ontology-based
analyses were performed using GenMAPP
software (Gene Map Annotator and Pathway
Proﬁler 2007) and the PANTHER database
(PANTHER Classiﬁcation System 2007).
Quantitative real-time reverse transcrip-
tase polymerase chain reaction. Total RNA
was puriﬁed using the Easy-Blue Total RNA
Extraction Kit (Intron Biotech, Korea) and
then used to synthesize single-strand cDNA in
a reaction mixture containing random hexam-
ers and Superscript II reverse transcriptase
(Invitrogen, Carlsbad, CA, USA). Gene-spe-
cific primers (Table 1) were designed using
Oligo 6.0 software (Molecular Biology
Insights, Cascade, CO, USA). Quantitative
real-time reverse transcription–polymerase
chain reaction (Q-PCR) was performed using
a Fast Start DNA Master SYBR Green I mix-
ture kit (Roche Diagnostics, Indianapolis, IN,
USA) in a Light Cycler system (Roche
Diagnostics) according to the manufacturer’s
protocol. To conﬁrm the speciﬁcity of ampli-
ﬁcation, we applied melting-curve analysis to
all ﬁnal PCR products.
Study subjects. The study was approved by
the institutional review board at the College of
Pharmacy, Seoul National University, and
written informed consent was obtained from
each subject. The study subjects consisted of
109 residents who had been living for more
than 2 weeks in new apartments built at the
end of 2005 (high-exposure group) and 20
control subjects who had been living in older
apartments built between 1981 and 1985
(low-exposure group). We evaluated FA expo-
sure by measuring the urinary concentration of
TZCA, a stable and quantitative cysteinyl
adduct of formaldehyde (Ratner and Clarke,
1937). Among residents whose urinary TZCA
concentrations were higher than the mean
TZCA concentration of the low-exposure
group (0.097 ± 0.040 mg/g creatinine),
17 subjects were enrolled in the main study.
Seven control subjects whose TZCA concen-
trations were lower than the mean of the low-
exposure group were also included. Overnight
urine and 20 mL of wholeblood were collected
and processed immediately. Initial clinical
investigations were performed. Blood samples
were mixed with RNA later (Ambion) and
stored at –80°C until use. After RNA puriﬁca-
tion, a total of 22 samples had RNA quality
that was suitable for Q-PCR. Because of the
lack of the statistically signiﬁcant difference in
the TZCA concentrations between the two
groups, all samples were further divided into
groups on the basis of the urinary concentra-
tion of TZCA.
Extraction of TZCA from urine. In a
15-mL test tube, 1.0 mL of urine sample was
placed. About 150 mg of ethylchloroformate,
1.5 mL of methanol/pyridine solution (4/1,
vol/vol) and d4-2-methyl-TZCA internal
standard solution (2.0 µL/mL in water) were
added to the solution, and the sample was
extracted with 3 mL of toluene by mechanical
shaking for 20 min. The organic phase was
dried to 0.1 mL under a nitrogen stream.
Measurement of the urinary concentra-
tion of TZCA. Samples were injected into the
gas chromatography (GC) system in split
mode at a split ratio of 1:10. All mass spectra
were obtained with an Agilent 6890/5973 N
instrument using the electron ionization
mode (EI; 70 eV, 150°C; Agilent). Full-scan
mass spectra (m/z 40–450) were recorded for
analyte identification. Helium was used as a
carrier gas at a ﬂow rate of 0.9 mL/min. The
GC operating temperatures were injector
temperature, 240°C; transfer line tempera-
ture, 280°C; oven temperature, programmed
to rise from 80°C to 240°C at 10°C/min
(held for 3 min). The ions selected for quan-
tification by selective ion monitoring (SIM)
were m/z 178 and 151 for d4-m-TZCA
(internal standard), m/z 174 and 147 for
m-TZCA, and m/z 160 and 133 for TZCA.
Calibration curves for TZCA and m-TZCA
were established by extraction and derivatiza-
tion after adding 20, 40, 100, 200, and
400 ng of standards and 200 ng of internal
standard to 1.0 mL of urine. The ratio of the
peak area of standard to that of internal stan-
dard was used to quantify the compound.
Statistical analysis. We used Graphpad
PRISM Software (San Diego, CA, USA) to
analyze the data. Differences between groups
were analyzed using one-way ANOVA fol-
lowed by Tukey’s multiple comparisons or
using t-tests. The relative gene expression
changes were expressed as the fold change
using the 2-ΔΔCT method (Livak and
Schmittgen 2001). Statistical signiﬁcance of
the fold change in gene expression between
control and exposure groups was analyzed
using t-tests. The correlation between
changes in gene expression (fold change) and
TZCA level was expressed as a Pearson coef-
ficient of correlation. The level of signifi-
cance for all analyses was set at 0.05.
Results
Identification of FA-responsive genes in
Hs 680.Tr cells. To establish an optimal con-
centration of FA for microarray analysis,
we incubated Hs 680.Tr cells with media
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Table 1. Gene-speciﬁc primers used in Q-PCR.
Gene NCBI RefSeqa Forward primer (5´–3´) Reverse primer (5´–3´)
PLK2 NM_006622 AGTTGTCAGCCTGAAAGTTGTAG CTGATAAGGCCCTAATGATGCTC
SGK NM_005627 TGAACTTCAGGGTGTTTGCAT ATGACGGTGAAAACTGAGGCT
SE20-4 NM_022117 ACAGGTGCTGGCCGATATG CCGACTCGATGGTAGAATCCC
BHLHB2 NM_003670 TGGTGAGCTGTCAGGGAGAAT GACAAGCTGCGAAGACTTCAGG
CCNL1 NM_020307 TGCAGTCACAGTGAAAGCCCT CGACTTGCTCTGAGATCGAGAAC
C8FW NM_020307 GTTGGGGACATGCACTCCTATG ACGTGGAGAAGACGAACTTCCTAA
HES1 NM_005524 GACAGGTGCTGGCCGATATG TTTCAGAGCATCCAAAATCAGTGT
FOSB NM_006732 AGCAGCAGCTAAATGCAGGA TTTTGGAGCTCGGCGATCT
DUSP2 NM_004418 TTTTCCGCTACAAGAGTATCCC GCCCACCAGTCCACAGTCAG
PPP1R15A NM_014330 TCCTCTGGCAATCCCCCATA GGAACTGCTGGTTTTCAGCC
NFKBIA NM_020529 CTCCGAGACTTTCGAGGAAATAC GCCATTGTAGTTGGTAGCCTTCA
NEU1 NM_000434 CTTTGCTGAGGCGAGGAAAAT CAATGAACGCTGTAGGAGACC
DDAH1 NM_012137 TTAGATGGCGGAGATGTTT TTGTCGTAGCGGTGGTC
NFATC1 NM_172390 AAGAAGATGGTCCTGTCTGGC TTATCCTCTGATTCCGAAATGG
NFKB1 NM_003998 GATTTCGTTTCCGTTATG CCTTGGGTCCAGCAGTT
aFrom the National Center for Biotechnology Information (NCBI), Entrez Nucleotide database (NCBI 2006a).containing FA (0, 20, 50, 100, and 200 µM)
and then determined cell viability using the
MTT colorimetric assay. The concentrations
of FA that induced the half-maximal cyto-
toxic effect (IC50) were 99.6 ± 1.1 µM at
4 hr and 69.0 ± 1.1 µM at 24 hr (Figure 1).
To minimize the ﬁxative effect of FA, which
increases with concentration and time, we
analyzed changes in gene expression after
4 hr of incubation with either 10 or 100 µM
FA. Illumina gene expression arrays contain-
ing more than 23,000 oligonucleotide
probes were used to analyze global gene
expression in duplicate control and triplicate
FA-treated Hs 680.Tr cells. Technical repli-
cates had a very high reproducibility, with
correlation coefficients of 0.92. One-way
ANOVA (p < 0.05), Tukey’s HSD test
(p < 0.05), and Benjamini-Hochberg data
correction of control and FA-treated cells
identified 1,369 genes [see Supplemental
Material (http://www.ehponline.org/docs/
2007/1018/suppl.pdf)].
Functional categorization of the data was
performed using annotation information in
the PANTHER database for ontology
(PANTHER Classification System 2007).
FA-induced changes in gene expression are
involved in a variety of biological processes.
The largest group of affected genes was asso-
ciated with nucleoside, nucleotide, and
nucleic acid metabolism, whereas genes
related to signal transduction, protein
metabolism, and developmental processes
were the next most abundant annotation
groups. Dendrogram tree analysis of the
genes showed patterns responsive to the
treatment conditions (Figure 2).
When the data were ﬁltered for a 2-fold
difference in expression level and a coefﬁcient
of variation (CV) < 0.02, 54 FA-responsive
genes were extracted (Table 2). Genes with-
out clear annotations, for example, expressed
sequence tags, were excluded from the table.
However, FA-responsive genes are not lim-
ited to these 54 genes but include all the
1,369 genes identified by the one-way
ANOVA, Tukey’s HSD test, and Benjamini-
Hochberg correction.
Validation of gene expression in Hs 680.Tr
cells by Q-PCR. We performed Q-PCR to vali-
date the microarray data. We selected genes
for Q-PCR on the basis of the magnitude and
direction (+/–) of gene expression from each
of the categories in Table 2, namely, signal
transduction, apoptosis, cell proliferation and
differentiation, cell cycle, developmental
process, immunity and defense, and intra-
cellular protein trafﬁc. We selected 15 of the
54 genes for Q-PCR analysis; these included
12 genes showing increased expression and
3 genes showing down-regulation in all
groups of FA-treated cells. Of all the genes
analyzed with Q-PCR, only PPP1R15A,
NFKB1A, and NEU1 expression differed
from the microarray results. However, in most
cases, there was good correlation between the
microarray analysis and Q-PCR (Table 3).
Characteristics of study subjects used for
validation of the candidate gene markers.
After demonstrating close agreement between
the two quantification methods for the
expression of genes listed in Table 3, we ana-
lyzed their expression in FA-exposed and
control subjects using Q-PCR. In the first
screening experiment, 109 new- and 20 old-
apartment residents were recruited, represent-
ing high- and low-exposure subjects,
respectively, and urine samples were collected
for the measurement of TZCA. The mean
concentration of TZCA in the low-exposure
group was 0.097 ± 0.04 mg/g creatinine,
whereas the mean of the high-exposure group
was 85.6% higher (0.180 ± 0.121 mg/g crea-
tinine; p < 0.003). All study subjects were
Korean and the demographic data are sum-
marized in Table 4. The age of subjects and
number of smokers were comparable between
the exposed and control groups. We then fur-
ther subdivided the test subjects. From the
exposed residents whose urinary TZCA con-
centrations were higher than the mean
TZCA concentration of the low-exposure
group, 17 subjects were enrolled in the sec-
ond experiment to analyze gene expression.
Seven of the control subjects whose TZCA
concentrations were lower than the mean of
the low-exposure group were also included.
However, 22 samples that had RNA quality
suitable for Q-PCR were further analyzed.
Effects of FA exposure on expression of the
differentially expressed genes. In the second
experiment, whole blood and urine samples
obtained from the subjects were analyzed by
Q-PCR for the expression of the selected
genes and by GC-MS for urinary excretion of
TZCA (Table 5). Because of the lack of sig-
nificant difference in TZCA concentration
between the control and exposed groups, we
reclassified the subjects into three groups
according to the urinary concentration of
TZCA. The low-TZCA group, representing
the lower 25% in TZCA concentration in all
test subjects, comprised subjects with TZCA
concentrations lower than 0.053 mg/g creati-
nine. The intermediate- (between 0.053 and
0.141 mg/g creatinine) and high-TZCA
groups (higher than 0.141 mg/g creatinine)
contained the subjects whose TZCA concen-
trations ranked the next 50% and the last
25% in all the test subjects. Demographics
details of the subjects in the second experi-
ments are listed in Table 5. We found no
Li et al.
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Figure 1. Acute cytotoxicity of formaldehyde (FA) in
Hs 680.Tr human tracheal fibroblasts. The cells
were incubated with increasing concentrations of
FA in medium containing 10% fetal bovine serum for
4 and 24 hr, after which viability was determined by
MTT assay. Results are expressed as the percent of
viable cells compared with solvent control.
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Figure 2. Hierarchical cluster analysis of differen-
tially expressed genes altered more than 2-fold in
formaldehyde-treated Hs 680.Tr cells. Cont, control.
The analysis was performed using 54 genes
obtained by adjustment of the data using the
Benjamini-Hochberg multiple test correction. Red
and green colors in the matrix indicate the relative
gene induction and repression, respectively. The
dendrogram groups genes according to overall
similarities in the gene expression proﬁle.statistically signiﬁcant differences in the dis-
tribution of age between groups. No smokers
participated in this study. The expression of
most genes tested showed good correlation
with FA exposure (Figure 3); of these,
BHLHB2, CCNL1, SE20-4, C8FW, PLK2,
and SGK were the most signiﬁcantly altered.
For BHLHB2, CCNL1, and SGK, gene
expression increased in a TZCA concentra-
tion-dependent manner, and the changes
were statistically significant between the
intermediate- and low-TZCA groups and
between the high- and low-TZCA groups. In
contrast, SE20-4, C8FW, and PLK2 showed
signiﬁcance only between the high- and low-
TZCA groups. Correlation analysis showed
that urinary TZCA concentrations were
closely correlated with gene expression for
C8FW and SGK. Another four genes showed
weak-to-moderate correlation with TZCA
level (Figure 4). Thus, these 6 genes are dif-
ferentially expressed following FA exposure in
humans and have the potential to be devel-
oped as FA biomarkers.
Discussion
FA is an environmental contaminant that
warrants concern for human health. Long-
term exposure to FA is closely associated
with adverse health effects ranging from irri-
tation and inﬂammation (Alexandersson and
Hedenstierna 1988; Kane and Alarie 1977)
to squamous cell carcinomas in the nasal cav-
ities (Kerns et al. 1983), depending on the
concentration and duration of exposure.
Animal and human studies have not shown
clear results with regard to the genotoxic
potential of FA. Evaluation of the available
data indicates that FA is genotoxic in vitro
(Speit and Merk 2002), although it is not
generally genotoxic in standard in vivo assays
(Speit et al. 2007). The carcinogenic effect of
FA is caused by prolonged regenerative cell
proliferation associated with its cytotoxicity,
which increases the number of DNA replica-
tions and thus increases the probability of
DNA–protein cross-link (DPX)-initiated
replication errors (Liteplo and Meek 2003;
Speit et al. 2000).
Because of its high chemical reactivity,
individuals exposed to low concentrations of
FA did not show any signiﬁcant differences
in the blood concentration of FA or urinary
concentration of formic acid compared with
controls (Gottschling et al. 1984). For this
reason the reaction of FA with macromole-
cules and the formation of DPX in periph-
eral blood lymphocytes have been used as
surrogate measures for FA exposure (Shaham
et al. 2003). However, DPX is not a speciﬁc
biomarker for FA; it also forms after expo-
sure to many other environmental chemicals
or ionizing radiation (Al-Nabulsi and
Wheeler 1999; Chakrabarti et al. 2001).
Identification of gene markers for formaldehyde
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Table 2. Genes altered more than 2-fold compared with control in the Hs.680 cells treated with FA. 
GenBank ANOVA t-Test Fold change CVb CV
accession no.a Gene symbol (p-Value) (p-Value) (100 µM) (0 µM) (100 µM)
Apoptosis
NM_014330.2 PPP1R15A 0.0006 0.0000 4.6 0.00 0.01
NM_022117.1 SE20-4 0.0044 0.0001 2.5 0.02 0.01
NM_005627.2 SGK 0.0013 0.0000 4.0 0.01 0.00
Carbohydrate metabolism
NM_005328.1 HAS2 0.0008 0.0000 –3.2 0.02 0.00
NM_080682.1 VCAM1 0.0022 0.0000 –4.6 0.02 0.02
Cell adhesion
NM_153742.3 CTH 0.0048 0.0001 2.1 0.01 0.00
Cell cycle
NM_020307.1 CCNL1 0.0038 0.0001 3.2 0.00 0.01
NM_031459.3 SESN2 0.0023 0.0000 2.2 0.01 0.01
NM_005461.3 MAFB 0.0002 0.0000 4.9 0.00 0.00
NM_006732.1 FOSB 0.0000 0.0000 52.0 0.01 0.00
NM_002228.3 JUN 0.0014 0.0000 2.6 0.00 0.01
NM_000076.1 CDKN1C 0.0022 0.0001 3.6 0.01 0.01
NM_004418.2 DUSP2 0.0001 0.0000 17.0 0.01 0.01
NM_006763.2 BTG2 0.0003 0.0000 7.9 0.00 0.00
NM_005159.2 ACTC 0.0015 0.0000 –2.9 0.01 0.00
NM_012197.2 RABGAP1 0.0010 0.0000 –2.6 0.00 0.00
NM_002581.3 PAPPA 0.0025 0.0001 –2.1 0.00 0.01
NM_012137.2 DDAH1 0.0110 0.0008 –2.2 0.01 0.01
Cell proliferation and differentiation
NM_003670.1 BHLHB2 0.0014 0.0000 2.8 0.01 0.00
Developmental processes
NM_005524.2 HES1 0.0003 0.0000 8.9 0.02 0.01
NM_000399.2 EGR2 0.0001 0.0000 15.9 0.01 0.01
NM_052943.2 MGC16491 0.0020 0.0000 2.3 0.01 0.01
NM_012258.2 HEY1 0.0022 0.0000 2.2 0.02 0.01
NM_017633.1 C6orf37 0.0004 0.0000 2.3 0.00 0.01
NM_001135.1 AGC1 0.0080 0.0003 –2.5 0.00 0.02
NM_032827.3 ATOH8 0.0159 0.0016 –2.2 0.02 0.01
Immunity and defense
NM_002155.3 HSPA6 0.0000 0.0000 64.4 0.01 0.01
NM_002014.2 FKBP4 0.0003 0.0000 2.8 0.00 0.01
NM_173173.1 NR4A2 0.0000 0.0000 4.1 0.00 0.00
NM_005252.2 FOS 0.0001 0.0000 62.1 0.01 0.01
NM_006291.2 TNFAIP2 0.0024 0.0000 –2.5 0.01 0.00
NM_003998.2 NFKB1 0.0003 0.0000 –2.8 0.00 0.00
NM_172390.1 NFATC1 0.0007 0.0000 –2.9 0.01 0.00
Intracellular protein trafﬁc
NM_001661.2 ARF4L 0.0008 0.0000 3.8 0.01 0.00
NM_000434.2 NEU1 0.0079 0.0003 2.2 0.02 0.00
Nucleoside, nucleotide, and nucleic acid metabolism
NM_031419.1 MAIL 0.0006 0.0000 6.2 0.01 0.01
NM_004089.2 DSIPI 0.0003 0.0000 3.1 0.00 0.01
NM_015001.2 SHARP 0.0038 0.0001 –2.2 0.01 0.01
Other metabolism
NM_032626.5 RBBP6 0.0009 0.0000 2.5 0.02 0.00
Protein metabolism and modiﬁcation
NM_152461.1 FLJ30999 0.0002 0.0000 6.6 0.01 0.01
NM_020338.1 RAI17 0.0040 0.0001 –2.4 0.00 0.00
Signal transduction
NM_001955.2 EDN1 0.0003 0.0000 5.2 0.01 0.00
NM_006622.1 PLK2 0.0025 0.0001 2.2 0.01 0.01
NM_025195.2 C8FW 0.0003 0.0000 4.0 0.00 0.01
NM_021158.3 C20orf97 0.0013 0.0000 3.7 0.01 0.00
NM_004165.1 RRAD 0.0003 0.0000 4.4 0.01 0.01
NM_020529.1 NFKBIA 0.0006 0.0000 3.7 0.00 0.00
NM_002928.2 RGS16 0.0010 0.0000 2.5 0.02 0.00
NM_016084.3 RASD1 0.0002 0.0000 4.9 0.00 0.01
NM_001511.1 CXCL1 0.0011 0.0000 3.0 0.01 0.01
NM_170662.2 CBLB 0.0054 0.0002 –2.6 0.02 0.00
Transport
NM_052901.1 MCSC 0.0014 0.0000 4.1 0.01 0.01
NM_024111.2 MGC4504 0.0044 0.0001 2.2 0.00 0.00
aFrom GenBank (NCBI 2006b). bCV is coefﬁcient of variation, which represents the ratio of the SD to the mean.Microarray technology for profiling
global gene expression has evolved and pro-
vides a powerful tool in the development of
biomarkers and the effects of exposure. A
critical hypothesis in this research area is that
the resulting transcript profile can provide
both reliable advance information on possible
toxic outcomes and mechanistic insight into
the toxicity itself. Although there is a recent
report regarding the gene transcription proﬁl-
ing of formaldehyde-exposed rats (Sul et al.
2007), this is the first investigation of the
effects of FA on the transcriptomal proﬁle in
humans using this technology. Our results
demonstrate that in a paired sampling study
design (control and FA-exposed individuals),
small changes in the gene expression proﬁle
can be measured from whole-blood total
RNA using a combination of microarray
hybridization and Q-PCR. It offers many
advantages, including the availability of a
huge number of candidate markers, the accu-
racy of the data, and the cost-effectiveness of
the experiments. This strategy is efﬁcient in
narrowing the number of candidates and
identifying biomarkers in human studies.
Our results show that this method is suitable
for assessing biomarkers of toxic effects and,
more speciﬁcally, that it can be used to ana-
lyze biomarkers of FA exposure.
A global analysis of more than 23,000
well-characterized human genes was per-
formed using an Illumina bead chip and FA-
exposed Hs 680.Tr. When the microarray
data from the control and FA-treated cells
were analyzed by ANOVA, about 6.0% of
the genes showed statistically significant
changes in expression. To control for the
increased chance of discovering false posi-
tives we used the Benjamini-Hochberg mul-
tiple testing correction method (FDR
< 0.05). Genes for Q-PCR confirmation
were selected from 54 differentially expressed
genes based on the fold change in expression
and the proposed functions of the genes. As
expected, the results obtained from microar-
ray experiments correlated well with Q-PCR,
although there were some examples that did
not match. One possible explanation is that
the Illumina probes for the well-correlated
genes are at the 3´ end of transcripts,
whereas the probes for the genes that do not
match span exons further upstream (Forrest
et al. 2005).
In the first set of people studied (129
subjects), the urinary TZCA concentration
in the exposed group was nearly double that
in the control group (p < 0.003). Although
we cannot exclude the possibility that factors
other than FA exposure may contribute to
TZCA formation, the majority of TZCA
excreted can be ascribed to FA exposure.
However, in the second experiment in
which only 22 human samples were ana-
lyzed, we found no statistical difference
between the control and exposure groups.
This was probably because of the small sam-
ple size and other potential sources of FA
exposure such as foods, disinfectants, preser-
vatives, and cosmetics (Naya and Nakanishi
2005; Oyama et al. 2002). Therefore, we
reclassified the subjects into three groups
according to urinary TZCA concentration,
namely, low-, intermediate-, and high-
TZCA groups. No one from the old apart-
ment complex was classified into the
high-TZCA group (Table 5). Using this clas-
sification, we found remarkable consistency
between the experimental in vitro microarray
data and Q-PCR results obtained from sub-
jects from real environmental exposure.
Among the 9 genes analyzed in human
blood samples, the expression of 6 genes,
namely, BHLHB2, CCNL1, SE20-4, C8FW,
PLK2, and SGK1, was signiﬁcantly higher in
the high-TZCA group than in the low-
TZCA group. For BHLHB2 and SGK1, the
increase was also signiﬁcant in the intermedi-
ate-TZCA group. These results indicate that
the combination of in vitro microarray
hybridization followed by Q-PCR validation
is a good tool for discovering genes that may
act as biomarkers, as well as for investigating
the early stages of environmental diseases.
Serum- and glucocorticoid-induced pro-
tein kinase 1 (SGK1) was originally identiﬁed
as an immediate early gene transcriptionally
induced by serum or glucocorticoids in
tumor cells (Webster et al. 1993a, 1993b).
However, its expression is ubiquitous and is
controlled by many cellular stresses. In
inﬂammatory and immune reactions, SGK1
expression is stimulated by proinﬂammatory
mediators, including tumor necrosis factor-α
(TNF-α) and lipopolysaccharide (Cowling
and Birnboim 2000). TNF-α levels are
reported to increase in response to FA expo-
sure (Bianchi et al. 2004). We found that FA
exposure activated SGK1 transcription,
demonstrating that SGK1 is useful as an early
indicator of FA exposure.
Basic helix–loop–helix protein (bHLH),
also known as DEC1, STRA13, Stra14, and
SHARP-2, is involved in chondrocyte and
neuronal differentiation (Boudjelal et al.
1997; Shen et al. 1997). Human DEC1 is
highly expressed in various tumor types but
not in the adjacent normal tissues, demon-
strating the signiﬁcance of this protein as an
oncogenic marker. Overexpression of bHLH
in HEK-293 cells causes the inhibition of
proliferation, blocks apoptosis induced by
serum deprivation, and selectively inhibits
the activation of procaspases (Li et al. 2002).
Li et al.
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Table 3. Q-PCR validation of selected genes from
microarray data.
Gene Microarray Q-PCR
PLK2 2.2 ± 0.1 1.8 ± 0.4
SGK 3.9 ± 0.2 3.4 ± 1.5
SE20-4 2.5 ± 0.2 2.4 ± 0.2
BHLHB2 2.8 ± 0.1 4.2 ± 0.2
CCNL1 3.1 ± 0.2 2.6 ± 0.4
C8FW 4.0 ± 0.2 2.3 ± 0.2
HES1 8.9 ± 0.9 1.7 ± 0.4
FOSB 52 ± 1.8 2.6 ± 0.1
DUSP2 17 ± 0.0 1.7 ± 0.1
PPP1R15A 4.6 ± 0.1 0.9 ± 0.2
NFKB1A 3.7 ± 0.3 0.9 ± 0.2
NEU1 2.2 ± 0.1 1.1 ± 0.1
DDAH1 –2.2 ± 0.0 –1.8 ± 0.1
NFATC1 –2.9 ± 0.0 –1.8 ± 0.2
NVKB1 –2.8 ± 0.0 –5.2 ± 0.8
Data are mean ± SD of three independent measurements,
which represent fold change on log2 scale compared with
data obtained from control group.
Table 4. Demographics of study subjects in the ﬁrst experiment.
Residents in
Characteristics Old apartment New apartment p-Value
No. of subjects 20 109
No. of smokers (%) 2 (10) 27 (24.8)
Age (years) 21.5 ± 2.1 28.6 ± 16.4 0.0532
Duration of residence (days) 87.0 ± 3.6 41.2 ± 13.0 < 0.001
TZCA concentration (mg/g creatinine) 0.097 ± 0.040 0.180 ± 0.121 < 0.003
Data are expressed as mean ± SD.
Table 5. Demographics of study subjects in the second experiment.
Group of subjects (TZCA concentration, mg/g creatinine)
Low TZCAa Intermediate TZCA High TZCA
Characteristics (TZCA ≤ 0.053) (0.053 < TZCA ≤ 0.141) (TZCA > 0.141) p-Valueb
No. of subjects 6 10 6
No. of smokers — — —
Age of subjects (years ± SD)  35.2 ± 13.4 22.3 ± 11.1 25.7 ± 16.3 0.194
(~ 15–52) (~ 10–49) (~ 12–42)
No. of new apartment residents 5 4 6
No. of old apartment residents 1 6 0
Mean TZCA concentration 0.033 ± 0.020 0.090 ± 0.032 0.219 ± 0.095 < 0.0001
aAll the subjects were separated into low-, intermediate-, and high-exposure groups on the basis of urinary TZCA con-
centration. Low- and high-exposure groups represent lower 25% and higher 25% in TZCA concentration of all the sub-
jects, respectively. bData are analyzed by one-way ANOVA and expressed as mean ± SD.Polo-like kinase-2 (PLK2) is a member of the
“polo” family of serine/threonine protein
kinases that play a role in cell division. PLK2
inhibits apoptosis by blocking cell cycle pro-
gression, thus maintaining genomic integrity.
The activation of PLK2 arrests the cell cycle
in the G2/M phase, and the loss of PLK2
increases apoptosis in cells (Burns et al. 2003).
Ectopic expression of TRIB1 (also known as
C8FW) in HeLa cells increased the extent and
rate of ERK phosphorylation in response to
PMA, indicating that TR1B1 plays a role in
the mitogen-activated protein kinase (MAPK)
signaling pathway (Kiss-Toth et al. 2004).
MAPK activation is an early event in the
response to a wide range of stimuli that induces
a wide variety of biological effects. For example,
MAPK activation is involved in the inhibition
of apoptosis, invasion, and metastasis of cancer
cells (Bhowmick et al. 2001; Janda et al. 2002).
According to Feick et al. (2006), the exposure
of intestinal epithelial cells to low doses of FA
leads to the phosphorylation of ERK-1/2 and
p38 MAP kinase. Our results demonstrate
that FA exposure in both experimental and
environmental settings caused transcriptional
activation of C8FW. Considering the anti-
apoptotic activity of FA in HT-29 human
colon carcinoma cells (Tyihak et al. 2001),
increased expression of BHLHB2, PLK2, and
C8FW mRNA after FA exposure may play
important roles in FA-induced inhibition of
apoptosis and carcinogenesis.
Cutaneous T-cell lymphoma-associated
tumor antigen (SE20-4), also known as differ-
entially expressed nucleolar transforming
growth factor (TGF)-β1 target protein
(DENTT), is a member of the TSPY/TSPY-
like/SET/NAP-1 superfamily whose mRNA is
overexpressed in TGF-β1-induced human
lung cancer cells (Ozbun et al. 2001). Cyclin
L1 (CCNL1) is a novel cyclin that plays roles
in cell cycle entry and is involved in the regu-
lation of RNA polymerase II transcription.
Transcriptional analysis in 20 head and neck
squamous cell carcinomas showed the overex-
pression of CCNL1 in all the tissues (Redon
et al. 2002). The upregulation of these two
cancer-related genes in the FA-exposed sub-
jects indicates that they may serve as early bio-
markers for FA-induced carcinogenesis.
In conclusion, we identified 54 FA-
responsive genes in human tracheal fibrob-
lasts. Among them 6 genes were upregulated
in the high urinary TZCA subjects.
Although blood cells are not representative
of all target cells for FA toxicity, dose-depen-
dent increases in the expression of a subset of
6 genes may provide insight into inﬂamma-
tion and carcinogenesis after FA exposure.
Further studies with larger sample sizes are
needed to deﬁne the dose–response relation-
ship between FA exposure and gene expres-
sion at the population level.
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